Director, Disease Strategy Finance

Vertex Inc.•Boston, MA

1d•Hybrid

About The Position

Vertex is growing at a rapid pace with challenging and exciting opportunities for motivated professionals who are keen to contribute to the Vertex mission to invest in scientific innovation to create transformative medicines for people with serious diseases. Our finance function is integral to achieving our company’s strategic goals, providing critical insights and analysis in support of decision-making across the organization. By joining our function, you will become part of a fast-moving, forward-thinking team to support the ongoing growth of a leader in the biotechnology industry. The Director of FP&A, DST Finance is a key member of Vertex's Financial Planning & Analysis organization, providing financial direction and strategic insights to cross-functional leaders. This role will partner closely with Disease Area Executives for assigned Disease Strategy Teams (“DSTs”) to help define and deliver against our goals. This role will provide strategic decision support, influence decisions and identify opportunities to invest, save costs and mitigate risks on a global basis. The role will also conduct corporate-level cross-functional valuations, modeling and other analysis to help drive our decision-making process.

Requirements

Bachelor’s degree in finance, Business, Economics or Accounting required.
10+ years of experience in FP&A, Strategy, Business Development, Portfolio Management, or related roles within the biotech, pharma, or life sciences industry, with a focus on a deep understanding of drug discovery, development, manufacturing, regulatory, and commercialization.
Expert analytical and financial modeling skills to evaluate a broad range of financial questions – especially valuation and strategic planning.
Excellent communication and presentation skills, with the ability to influence stakeholders at all levels and a proven ability to present complex financial insights to senior stakeholders.
Demonstrated success in leading process improvement and change management initiatives.

Nice To Haves

MBA and/or other advanced degree preferred.
Experience in healthcare, pharmaceuticals, biotech or consulting.
Business partnering with C-Suite and executive level members of the organization.
Strategic thinking and problem-solving.
Strong analytical and financial modeling skills to evaluate a broad range of financial questions – especially portfolio analysis, valuation, and complex business questions.
Expertise with Excel and PowerPoint; Working knowledge of Hyperion or similar enterprise planning tools.
Ability to lead and drive change in an evolving business environment, coordinating processes involving large numbers of people, complex systems, and tight deadlines to deliver innovative solutions.
Strong business acumen and judgment, and knowledge of the company's markets/products and industry trends.
Strong communication skills, both written and verbal, and an eagerness to collaborate with colleagues (within or outside of finance) in sharing insights and learnings and partnering to ensure timely execution of project plans.
Possesses a continuous improvement mindset, with flexibility and ability to adapt to change.

Responsibilities

Represents Finance in DSTs across the organization, coordinates appropriate financial analyses, and drives the development of reporting and analytics for each program.
Provides strategic decision support to enable clear understanding of financial impacts of potential business cases and/or planning scenario for multiple diseases at different stages of development.
Partners with Disease Area Executives, Program Managers and a wide range of core members from different areas of Vertex represented on Disease Strategy Teams.
Coordinates with other members of the finance team including Corporate, BD, R&D, Commercial, BSMO Finance as well as other CFO organization areas such as Accounting, Tax, and Treasury, promoting strong communication and collaboration across.
Proactively identifies, designs and implements enhancements to existing processes to drive efficiency across the teams.
Represents DST Finance as a center of excellence for all modeling, valuation and ad hoc analysis used for a wide range of decisions, including presentations at Executive Committee level meetings.
Opportunity to help build a high-performing Finance team that meets increasing needs and requirements across the business and helps drive the overall organization forward.